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Available online 25 January 2016Cerebral autoregulation represents the physiologicalmechanisms that keep brain perfusion relatively constant in
the face of changes inblood pressure and thus plays anessential role in normal brain function. This study assessed
cerebral autoregulation in nine newborns with moderate-to-severe hypoxic–ischemic encephalopathy (HIE).
These neonates received hypothermic therapy during the ﬁrst 72 h of life while mean arterial pressure (MAP)
and cerebral tissue oxygenation saturation (SctO2) were continuously recorded. Wavelet coherence analysis,
which is a time-frequency domain approach, was used to characterize the dynamic relationship between spon-
taneous oscillations in MAP and SctO2. Wavelet-based metrics of phase, coherence and gain were derived for
quantitative evaluation of cerebral autoregulation. We found cerebral autoregulation in neonates with HIE was
time-scale-dependent in nature. Speciﬁcally, the spontaneous changes inMAP and SctO2 had in-phase coherence
at time scales of less than 80min (b0.0002 Hz in frequency), whereas they showed anti-phase coherence at time
scales of around 2.5 h (~0.0001Hz in frequency). Both the in-phase and anti-phase coherence appeared to be re-
lated toworse clinical outcomes. Theseﬁndings suggest the potential clinical use ofwavelet coherence analysis to
assess dynamic cerebral autoregulation in neonatal HIE during hypothermia.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Hypoxic–ischemic encephalopathy (HIE)
Hypothermia
Cerebral autoregulation
Near infrared spectroscopy (NIRS)
Wavelet coherence1. Introduction
Birth asphyxia is a global burden in clinical neonatal care (Levene
et al., 1985). Every year four million newborns are affected worldwide,
of which one million die and another million are left with disabilities.
Hypothermia is a neuroprotective therapy to improve clinical outcomes
by reducing body temperature of newborns for a speciﬁc duration of
time (Shankaran et al., 2005). However, even following the introduction
of hypothermic therapy for neonatal hypoxic–ischemic encephalopathy
(HIE), approximately 40% of newborns still have neurodevelopmental
abnormalities at 24 months of age (Zonta et al., 2003; Bryce et al.,
2005; Higgins et al., 2011). A better understanding of pathophysiologi-
cal mechanisms of HIE-related brain injury is essential for developing
new effective interventions to improve clinical outcomes.
The healthy brain is protected by themechanisms of cerebral autoreg-
ulation,whichmaintains cerebral bloodﬂow(CBF) at a relatively constant
rate across a wide range of arterial blood pressures. In asphyxiated new-
borns, invasive positron emission tomography (PET) studies reportedTexas Southwestern Medical
X 75390-9063, United States.
halak).
. This is an open access article underimpairment of cerebral autoregulation with associated vasoparalysis
(Pryds et al., 1990). However, it remains unknownwhether hypothermic
therapy in asphyxiated newborns alters cerebral autoregulation. In addi-
tion, there is a lack ofmethodology that can quantify cerebral autoregula-
tion non-invasively and reliably at the bedside.
In the last decade, signiﬁcant progress has been made in developing
methods to assess cerebral autoregulation based on spontaneous oscilla-
tions in blood pressure, CBF, and cerebral oxygenation (Panerai, 1998).
Both CBF and cerebral oxygenation can be measured with non-invasive
techniques. Speciﬁcally, blood ﬂow velocity in the basal cerebral arteries
can be measured using transcranial Doppler (TCD) ultrasonography
(Aaslid et al., 1982), and cerebral oxygenation can be measured with
near-infrared spectroscopy (NIRS) represented as either the difference
between the oxygenated and deoxygenated hemoglobin (HbD =
HbO2− Hb) (Tsuji et al., 2000; Soul et al., 2007; Govindan et al., 2014)
or cerebral tissue oxygen saturation (SctO2) (Caicedo et al., 2011a;
Caicedo et al., 2011b; Gilmore et al., 2011; Wong et al., 2012). Both vari-
ables are reliable surrogates for changes in CBF as demonstrated in animal
models (Tsuji et al., 1998; Brady et al., 2007; Brady et al., 2008;Hahn et al.,
2011; Lee et al., 2011; Lee et al., 2012). In particular, SctO2 is less prone to
the movement artifacts during continuous, long-term measurements as
compared with HbD (van Bel et al., 2008; Caicedo et al., 2011a).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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blood pressure, referred to as dynamic cerebral autoregulation, transfer
function (Zhang et al., 1998) and other analysis methods for dynamic
systems have been developed (Liu et al., 2015). These methods are
often based on an assumption that changes in blood pressure and cere-
bral hemodynamics are stationary, that is, assuming the statistical prop-
erties of these variables do not change with time. In reality, blood
pressure and cerebral hemodynamics are non-stationary in nature, par-
ticularly under pathophysiological conditions (Panerai, 2014). Hence,
better tools are needed to characterize the non-stationary aspects of ce-
rebral autoregulation.
Continuous wavelet transform (CWT) is a powerful mathematical
tool for time-frequency domain analysis of stationary and non-
stationary time series (Torrence and Compo, 1998; Mallat, 1999).
Wavelet coherence analysis, based on CWT, characterizes intermittent
cross-correlations between two time series at multiple time scales
(Grinsted et al., 2004), which makes no assumption about the station-
arity of input signals. In this study, we introduced wavelet coherence
analysis to assess dynamic cerebral autoregulation in newborns with
HIE. All hemodynamic data, including mean arterial pressure (MAP)
and SctO2, were recorded continuously during the ﬁrst 72 h of life
under hypothermic therapy. Wavelet coherence analysis was per-
formed to quantify the spectral power and the dynamic relationship be-
tween spontaneous oscillations in MAP and SctO2. Wavelet-based
metrics of phase, coherence and gainwere derived for quantitative eval-
uation of cerebral autoregulation. Potential prognostic values of these
metrics for clinical magnetic resonance imaging (MRI) and
neurodevelopmental outcomes were explored to reveal short- and
long-term neurologic complications in HIE patients.
2. Materials and methods
2.1. Subjects, clinical care and outcome evaluations
This study included newborn infants at ≥36 weeks of gestation with
a birth weight of ≥1800 g whowere admitted to the neonatal intensive
care unit at Parkland Hospital, Dallas, TX, from January 2011 to January
2012. These newborns had perinatal asphyxia or metabolic acidosis, in-
cluding a clinical symptom of moderate to severe encephalopathy
within the ﬁrst six hours of birth. The study was approved by the Insti-
tutional Review Board of the University of Texas Southwestern Medical
Center and informed consent was obtained from parents before
enrollment.
Perinatal acidemia was determined by blood gases measured from
umbilical arterial blood during delivery. The criteria included a pH of
7.0 or less, a base deﬁcit of 16 mEq/L or greater in umbilical artery
blood, or any postnatal blood sample within one hour of life. In order
to establish the diagnosis of encephalopathy, a neurological examina-
tion was performed within six hours of birth according to the National
Institute of Child Health and Human Development (NICHD) classiﬁca-
tion for modiﬁed Sarnat staging (Sarnat and Sarnat, 1976), which
assessed 1) level of consciousness, 2) spontaneous activity, 3) posture,
4) tone, 5) primitive reﬂexes, and 6) autonomic nervous system. New-
borns that were diagnosed with moderate or severe encephalopathy
for at least three of the six categories were abnormal and would receive
hypothermic therapy (Shankaran et al., 2005). Whole-body hypother-
mia was initiated within six hours after birth and achieved by placing
the newborns on a cooling blanket (Blanketrol II, Cincinnati Sub-Zero).
The esophageal temperature was maintained at 33.5 °C by the blanket
servomechanism for 72 h. Then whole-body rewarming was initiated
by increasing the temperature of the blanket by 0.5 °C per hour using
the previously published protocols (Shankaran et al., 2005).
Clinical outcome of the hypothermic therapy was evaluated in two
stages: First, 3-Tesla MRI (Philips Healthcare Systems, TX) was per-
formed on eachHIE survivorwithin 5–8 days of age for evidence of neu-
rological abnormalities and injuries. MRI ﬁndings were scored forabnormalities by an experienced pediatric neuro-radiologist based on
the NICHD summary classiﬁcation, which has been validated in this
population to predict outcomes following hypothermia (Chalak et al.,
2014b; Rollins et al., 2014). Second, outpatient neurodevelopmental
follow-ups were performed at 18 to 24 months of age using the previ-
ously published protocol (Chalak et al., 2014a). Bayley-III scales of
neurodevelopment were rated in three domains: cognitive, language
and motor. Neurodevelopmental delay was identiﬁed by at least one
Bayley-III scale b85 or cerebral palsy.
2.2. Blood pressure and NIRS monitoring
Intra-arterial blood pressurewas continuouslymeasured from an in-
dwelling umbilical arterial catheter. Regional SctO2 was measured on
the frontoparietal side of the neonate's head using an INVOS™ 4100–
5100 oximetry (Somanetics, Troy, MI) and a neonatal sensor. Both
MAP and SctO2 data were sampled at a rate of two data points per min-
ute and recorded synchronouslywith aVital Sync™ system(Somanetics
Corporation, Troy, Michigan).
The MAP and SctO2 data were collected only under clinically stable
conditions (pCO2 between 40 to 50 mm Hg and hemoglobin level be-
tween 12 to 15 mg/dl). Therefore, the actual length of recorded data
was less than 72 h and varied case by case. Neonates were selected
only if they did not require any vasopressor medications, to avoid po-
tential drug effects on cerebral autoregulation.
2.3. Data preprocessing
Both theMAP and SctO2 data were ﬁrst inspected to identify artifacts
thatwere deﬁned as a sharp change of signals greater than 15% from the
baseline. These spikes were removed by linear interpolation. Then a
second-order polynomial detrending was applied to remove the slow
drifts from each time series.
2.4. Wavelet coherence analysis
Wavelet coherence analysis is based on CWT, which decomposes a
time series in time-frequency domain by successively convolving the
time series with the scaled and translated versions of a mother wavelet
function ψ0 (Mallat, 1999). The continuous wavelet transform of a time
series x(n) of length N, which is sampled from a continuous signal at a
time step of Δt, is deﬁned as:
WX n; sð Þ ¼
ﬃﬃﬃﬃﬃ
Δt
s
r XN
n0−n
x nð Þ0 n0−nð Þ
Δt
s
  
ð1Þ
where n is a time index, s denotes the time scale that is in inverse pro-
portion to frequency, and ⁎ indicates the complex conjugate.
In analogy to Fourier analysis, a wavelet power spectrum of x(n) can
be deﬁned as thewavelet transformation of its autocorrelation function,
which is implemented as follows:
WXX n; sð Þ ¼ WX n; sð ÞWX n; sð Þ: ð2Þ
The auto-wavelet power spectrumWXX(n,s) is a real function, which
describes the power of x(n) in the time-frequency domain.
Similarly, the cross-wavelet transform of two time series, x(n) and y
(n), is deﬁned as:
WXX n; sð Þ ¼ WX n; sð ÞWY n; sð Þ: ð3Þ
Themodulus |WXY(n,s)| represents the amount of joint power between
x(n) and y(n), and the complex argument Δφðn; sÞ ¼ tan−1fIm½WXY ðn;sÞ
Re½WXY ðn;sÞg
represents the relative phase between x(n) and y(n).
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et al., 1998), a wavelet transfer function can be deﬁned as:
H n; sð Þ ¼
S S−1WXY n; sð Þ
h i
S S−1WXX n; sð Þ
h i ð4Þ
where S is a smoothing operator in the time-frequency (scale) domain.
The smoothing process is necessary to remove the singularities inwave-
let power spectra of x(n) to improve the reliability of H(n,s) estimation
(Torrence and Compo, 1998). It can be done using a weighted running
average in both the time and scale directions, as given by Torrence
and Webster (1999). The modulus of wavelet transfer function, |H(n,
s)|, represents the relative amplitude (gain) between x(n) and y(n).
The complex argument of wavelet transfer function represents the
phase relationship between x(n) and y(n).
Similar to the magnitude-squared coherence (MSC) function based
on Fourier transform (Zhang et al., 1998), a squared cross-wavelet co-
herence R2(n, s) is deﬁned as (Torrence and Webster, 1999):
R2 n; sð Þ ¼
S S−1WXY n; sð Þ
h i 2
S S−1 WX n; sð Þ
 2SS−1 WY n; sð Þ 2
  ð5Þ
where R2(n, s) ranges between 0 and 1 and can be conceptualized as a
localized correlation coefﬁcient between x(n) and y(n) in the time-
frequency domain. The statistical signiﬁcance level of R2(n,s) can be es-
timated based on aMonte Carlo simulation of a stochastic Gaussian pro-
cess (Maraun and Kurths, 2004). Brieﬂy, a large ensemble of surrogate
data pairs (n = 1000) can be generated with bootstrapping (Efron
and Tibshirani, 1993), which has the same coefﬁcients as the real
input data pair based on the ﬁrst-order autoregressive (AR1) model
(Grinsted et al., 2004). Then wavelet coherence is calculated for all of
the simulated data pairs. The signiﬁcance level of coherence of the real
input data pair is determined by comparingwith the statistical distribu-
tion of those obtained from the surrogate data pairs at each time and
wavelet scale.
In this study, we used a MATLAB-based software package (Grinsted
et al., 2004) for wavelet coherence analysis between the spontaneous
oscillations ofMAP and SctO2 (MAP→ SctO2). This software package em-
ploys a Morlet wavelet (withΩ0 = 6) as the mother wavelet ψ0, which
provides a good trade-off between time and frequency localization
(Grinsted et al., 2004). We conﬁrmed that both the MAP and SctO2
changes as input data were normally distributed, and their Fourier
power spectra could be approximated by the AR1 models in this soft-
ware package. A 95% conﬁdence interval (p b 0.05) was used for statis-
tical testing of the estimatedwavelet coherence. A comparison between
the results from wavelet coherence analysis and transfer function anal-
ysis based on two simulated, stationary time series is given in Supple-
mentary material I.
2.5. Quantifying results from wavelet coherence analysis
To quantitatively evaluate the status of cerebral autoregulation
based on wavelet analysis, we ﬁrst deﬁned four phase ranges:
1)Δφ=0± π/4, 2) π/2 ± π/4, 3) π± π/4, and 4)−π/2 ± π/4 to char-
acterize the relationship between the changes in MAP and SctO2. Each
phase represented a distinct pattern of coherence and might be related
to different underlying mechanisms: Δφ= 0 ± π/4 represented an in-
phase coherencewhere theMAP and SctO2 oscillated in same directions,
Δφ=π±π/4 represented an anti-phase coherencewhere theMAPand
SctO2 oscillated in opposite directions,Δφ= π/2± π/4 and−π/2± π/4
represented where the MAP and SctO2 oscillated with signiﬁcant phase
differences. Therefore, it was important to quantify these patterns sep-
arately. Within each phase range, we further deﬁned and quantiﬁedtwo wavelet-derived metrics, namely, percentage of signiﬁcant coher-
ence P(s) and wavelet transfer function gain G(s), as follows:
1) The percentage of signiﬁcant coherence P(s) was calculated at each
wavelet time scale as the percentage of time during which the
squared cross-wavelet coherence R2 was signiﬁcantly different
from the simulated Gaussian process (p b 0.05). P(s) was scale-
dependent, as shown in Fig. 1(c). It reﬂected the overall degree at
which theMAP and SctO2were correlated at each time scale. Further,
for a speciﬁc range of time scale, a cross-scale mean value Pmeanwas
determined for each of the four phase ranges.
2) The wavelet transfer function gain G(s) was calculated as the mean
value of gain at each time scale over the periodswhere R2 was statis-
tically signiﬁcant (p b 0.05). G(s) was also scale-dependent. For a
speciﬁc range of time scale, a cross-scale mean value Gmean was de-
termined within the periods of signiﬁcant coherence for each of
the four phase ranges.
In addition, both P(s) and G(s) were calculated outside the cone of
inﬂuence (COI) to avoid any edge effect.
2.6. Classiﬁcation and cross-validation
In order to explore the possibility of using wavelet-derived metrics
as early predictors for clinical outcomes, we utilized a linear support
vector machine (SVM) classiﬁer (Cristianini and Shawe-Taylor, 2000)
with leave-one-out cross-validation (LOOCV) (Hjorth, 1994). SVM is a
commonly used algorithm in machine learning for pattern recognition
and data classiﬁcation, while LOOCV is a special case of leave-k-out
cross validation when k is equal to one (Shao, 1993). In LOOCV, one ob-
servation is left out as a test set while the remaining observations are
used as a training set to construct a classiﬁcation model. Then, the
model-building and validation process continues until every observa-
tion has served as a test set once through the entire data space. The
LOOCV analysis utilizes the available data most efﬁciently since only
one observation is left out at each step. Therefore, it has been widely
used in studies with small sample sizes (Georgakoudi et al., 2001;
Volynskaya et al., 2008; Tian et al., 2009; Derosiere et al., 2014).
In this study, the wavelet-derived metrics (Pmean and Gmean in four
different phase ranges, as described in Section 2.5) from each neonate
afforded eight maximal features that could be used to construct the
SVM classiﬁer for predicting “normal outcome” or “abnormal outcome”
and be cross-validated by LOOCV. Speciﬁcally, at each step, one
neonate's data was selected as a test set and the remaining eight neo-
nates' data were used as a training set for constructing the classiﬁer.
This process was repeated nine times to complete the LOOCV analysis.
At last, the classiﬁcation accuracy across all patients was determined
by the percentage of correctly classiﬁed patients over the total.
3. Results
Twenty newborns with a gestational age of 39 ± 2 weeks received
whole-body hypothermic therapy for 72 h for moderate (n= 17) and
severe encephalopathy (n=3) during the studyperiod. They all had ev-
idence of multiple organ involvement. Exclusions were done according
to the predeﬁned criteria: clinical instability with hypoxia and pulmo-
nary hypertension (n= 3), SctO2 continually exceeding upper limit of
95% for more than 4–6 h (n = 4), lack of continuous recording (n =
3), and no consent (n = 1). Thus, nine neonates (moderate/severe =
7/2) had complete monitoring data and were analyzed in this report.
Among these nine neonates, one died after extracorporeal membrane
oxygenation (ECMO) following hypothermia; four had abnormal MRIs
with evidence of diffuse white matter injury and watershed infarcts
and/or neurodevelopmental delays with at least one Bayley III scale
b85; the remaining four had normal outcomes. Individual characteris-
tics and clinical outcomes of these neonates are summarized in Table 1.
Fig. 1.Quantiﬁcation of results inwavelet coherence analysis: (a) Squared cross-wavelet coherence, RMAP→SctO2
2(n,s), from aHIE neonate. The x-axis represents time, the y-axis represents
scale (which has been converted to the equivalent Fourier period), and the color scale represents themagnitude of R2. The cone of inﬂuence (COI)where edge effects should be considered
is shown as a lighter shade. The black line contours designate areas of signiﬁcant coherence (p b 0.05). The arrows designate the relative phase between MAP and SctO2: a rightward-
pointing arrow indicates in-phase coherence between the two signals (Δφ= 0), a leftward-pointing arrow indicates anti-phase coherence (Δφ= π). (b) Regions of signiﬁcant
coherence (p b 0.05) are classiﬁed into four phase ranges: Δφ= 0 ± π/4 (cyan), π/2 ± π/4 (green), π± π/4 (purple), and−π/2 ± π/4 (red). Regions of non-signiﬁcant coherence
and/or with edge effect appear as blue background. (c) Percentage of signiﬁcant coherence, P(s), is quantiﬁed in each of the four phase ranges. P(s) was a function of scale, which is
plotted on the y axis (that has been converted to equivalent Fourier period). At each scale, P(s) was calculated as the percentage of time during which the R2 was statistically
signiﬁcant (p b 0.05).
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clinically stable, artifacts were only detected at a number of isolated
time points. Thus, wavelet analysis was conducted on the complete,
continuous data from each patient after removing the artiﬁcial spikes.
The results of wavelet coherence from all of the nine individual neo-
nates are given in Supplementary material II.
3.1. Characteristics of phase, coherence and gain between MAP and SctO2
oscillations
All of the neonates with normal clinical outcomes showed non-
signiﬁcant MAP→ SctO2 coherence most of the time during hypother-
mia, indicating that the spontaneous oscillations of SctO2were largely ir-
relevant to the systemic changes in blood pressure. In contrast,
signiﬁcant MAP→ SctO2 coherence was observed among the neonates
with abnormal outcomes, which was often sustained for hours to days
and in different ranges of the wavelet time scale. Two individual exam-
ples are detailed below:
Fig. 2(a) shows the MAP→ SctO2 coherence from a neonate who re-
ceivedwhole-body hypothermia for moderate encephalopathy (Patient
#7). Intermittent in-phase coherence between the MAP and SctO2
changes was observed in a scale range of 8 to 64min. This phenomenon
was further conﬁrmed in a segment of real-timedata shown in Fig. 2(b).
In addition, Fig. 2(a) also shows a transient, anti-phaseMAP→ SctO2 co-
herence at the early stage of hypothermia that locates in a longer scale
range of 256 to 512 min. The signiﬁcant, intermittent in-phase coher-
ence between the MAP and SctO2 changes indicated that the patient's
cerebral oxygenation was passive to the blood pressure changes duringTable 1
Individual characteristics and clinical outcomes of the nine neonates reported in this study.
Patient # Gender Gestation age (week) Encepha
1 F 40 Moderat
2⁎ M 39 Severe
3 M 42 Moderat
4 M 37 Moderat
5 F 38 Severe
6⁎ F 36 Moderat
7 M 40 Moderat
8⁎ F 38 Moderat
9⁎ M 36 Moderat
⁎ Neonates with normal clinical outcomes.hypothermia, a vital sign of an impaired autoregulation system (Soul
et al., 2007). Following the treatment, the neonate was transferred to
ECMO because of severe pulmonary hypertension and subsequently
died after withdrawal of care.
Fig. 2(c) shows theMAP→ SctO2 coherence from a neonate whowas
treated for severe encephalopathy (Patient #5). A predominant anti-
phase coherence between the MAP and SctO2 oscillations was observed
in a scale range of 64 to 256 min. This phenomenon was further con-
ﬁrmed in a segment of real-time data shown in Fig. 2(d), in which
both MAP and SctO2 oscillated at a periodicity of around 2 h and in a
clear anti-phase relationship. Post-treatment evaluations showed the
patient had both abnormal MRIs prior to hospital discharge and severe
neurodevelopmental delays at 2 years of age (all of the Bayley III scales
were b85).
At group level, the signiﬁcant in-phase and anti-phase MAP→ SctO2
coherence among the patients with abnormal outcomes were scale-
dependent (Fig. 3). The in-phaseMAP→ SctO2 coherencewas represented
mostly in a shorter scale range below 80minwith a peak around 7.5min.
In contrast, the signiﬁcant anti-phase MAP→ SctO2 coherence was repre-
sented in a much broader scale range with a peak at about 2.5 h.
Neither the normal-outcome group nor the abnormal-outcome
group had signiﬁcant MAP→ SctO2 coherence in the other two phase
ranges, namely Δφ = π/2 ± π/4 and −π/2 ± π/4. These two phase
ranges seemed irrelevant to the status of cerebral autoregulation. There-
fore, the results from these two phase ranges were not utilized in the
analysis hereafter.
Further quantiﬁcation of results was conducted in a predeﬁned scale
range of 7.5 min to 5 h. Here the upper bound was selected because oflopathy MRI Bayley-III (cognitive/language/motor)
e Normal 50/75/89
Normal 100/90/85
e Normal 77/75/94
e Normal 70/68/91
Abnormal 55/74/82
e Normal 90/91/85
e Death Death
e Normal 85/91/94
e Normal 85/97/88
Fig. 2.Wavelet-based MAP→ SctO2 coherence in two neonates with abnormal outcomes: (a) In this squared cross-wavelet coherence, RMAP→SctO2
2(n,s), from the ﬁrst neonate who was
treated for moderate encephalopathy, the x-axis represents time, the y-axis represents scale (which has been converted to equivalent Fourier period), and the color scale represents the
magnitude of R2. The cone of inﬂuence (COI) where edge effects should be considered is shown as a lighter shade. The black line contours designate areas of signiﬁcant coherence
(p b 0.05). The arrows designate the relative phase between MAP and SctO2: a rightward-pointing arrow indicates in-phase coherence between the two signals (Δφ= 0), a leftward-
pointing arrow indicates anti-phase coherence (Δφ= π). (b) An enlarged segment of the real-time MAP and SctO2 data from the ﬁrst neonate. The two signals ﬂuctuate synchronously
in a clear in-phase relationship. (c) Squared cross-wavelet coherence, RMAP→SctO2
2(n,s), is shown from the second neonate who was treated for severe encephalopathy. (d) An enlarged
segment of the real-time MAP and SctO2 data is shown from the second neonate. The two signals ﬂuctuate in a clear anti-phase relationship with a periodicity of around 2 h.
128 F. Tian et al. / NeuroImage: Clinical 11 (2016) 124–132the signiﬁcant edge effect of CWT in time scales longer than 5 h; and
the lower bound was selected to constrain the inﬂuence of transient
noises. The group-averaged mean percentage of signiﬁcant coher-
ence, Pmean, and the associated mean gain, Gmean, were calculated
within the predeﬁned scale range. Overall, patients with abnormal
outcomes showed either a greater in-phase Pmean (p = 0.15, two-
sample t-test) or a greater anti-phase Pmean (p = 0.27, two-sample
t-test) than the patients with normal outcomes as shown in Fig 4
(a). The abnormal-outcome group also showed either a higher in-
phase Gmean (p = 0.03, two-sample t-test) or a higher anti-phaseFig. 3. Scale-dependent percentage of signiﬁcant MAP→ SctO2 coherence, P(s), quantiﬁed in tw
denote the group-averaged values and the shaded regions denote the standard errors.Gmean (p = 0.39, two-sample t-test) than the normal-outcome
group as shown in Fig 4(b).
3.2. Predictive accuracy of clinical outcomes based on the wavelet-derived
metrics
Table 2 summarizes the accuracy of wavelet-derived metrics in
predicting the patients' clinical outcomes, which was estimated by the
LOOCV analysis with linear SVM classiﬁers. The predictive accuracy var-
ied from 66.7% to 88.9% based on the use of different combinations ofo phase ranges: (a) Δφ= 0± π/4, and (b) Δφ= π± π/4. In each graph, the solid lines
Fig. 4.Wavelet coherence and gain estimation at group level: (a) mean percentage of the signiﬁcant coherence, Pmean, over the time scales of 7.5 min to 5 h, and (b)mean gain associated
with the signiﬁcant coherence, Gmean. In each graph, the data are plotted as mean ± standard error.
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the in-phase and anti-phase measures of phase and gain were utilized.
4. Discussion
The current study assessed cerebral autoregulation in neonates with
HIE by employing a novel wavelet coherence analysis to characterize
the dynamic relationship between the spontaneous MAP and SctO2 os-
cillations, while the neonates were receiving hypothermic therapy dur-
ing theﬁrst 72 h of life. Thewavelet-derivedmetrics of phase, coherence
and gain for quantitative evaluation of cerebral autoregulation indicate
a potential to use this methodology to predict clinical outcomes during
early phase of neonatal care at the bedside.
Asphyxia startswith a fetal insult due to ischemic attack that impairs
CBF regulation as a consequence of a substantial interruption of mater-
nal and/or fetal placental blood ﬂow and gas exchange (Shalak and
Perlman, 2004). The timing, severity, pattern and duration of the fetal
insults as well as the degree of recovery via fetal compensatory and/or
adaptive mechanisms determine the spectrum of disease, outcomes
and possibly the responses to therapy. While hypothermic therapy pro-
vides neuroprotection viamultiple pathways, including the reduction in
cerebral metabolism as well as CBF (Laptook et al., 1999; Laptook et al.,
2001; Laptook, 2009), a signiﬁcant knowledge gap exists regarding how
to viably assess cerebrovascular functions in general, and cerebral auto-
regulation in particular, during the treatment and more importantly,
how potential impairment in cerebral autoregulation may be related
to the clinical outcomes.
Previous studies evaluating cerebral autoregulation in newborns
have utilized technically challenging imaging modalities for CBF mea-
surement such as PET, single photon emission computed tomography
(SPECT), or perfusion-weighted MRI. Other more recent studies have
recognized the utility of non-invasive NIRS measurements (Greisen,
2006), and have linked high cerebral oxygen saturation, a pattern indic-
ative of irreversible brain injury, to the death and poor neuro-
developmental outcomes in HIE patients (Meek et al., 1999; Toet et al.,
2006; Ancora et al., 2013; Lemmers et al., 2013). Autoregulation in pre-
term newborns has been extensively and elegantly studied non-
invasively by quantifying the coherence over short time scales using
NIRS-derived HbD and SctO2 (Tsuji et al., 2000; Soul et al., 2007;
Govindan et al., 2014). In the present study,we chose to use SctO2 rather
than HbD as an index of cerebral blood ﬂow dynamics, as the former isTable 2
Accuracy of wavelet-derived metrics in predicting the patients' clinical outcomes.
Parameters Predictive accuracy
In-phase Pmean, anti-phase Pmean 77.8%
In-phase Gmean, anti-phase Gmean 66.7%
In-phase Pmean & Gmean, anti-phase Pmean & Gmean 88.9%less sensitive to movement artifact (van Bel et al., 2008; Caicedo et al.,
2011a) and therefore more suitable for the purpose of long time scale
recording. Moreover, SctO2 has been validated to correlate well with
MRI arterial spin label cerebral blood ﬂow in the setting of HIE
(Wintermark et al., 2014).
Possible confounders involve the properties of SctO2which can be af-
fected by arterial saturation, CBF, cerebral blood volume and cerebral
oxygen consumption (van Bel et al., 2008; Chalak et al., 2014c). There-
fore, these variables need to be stable in order for SctO2 to reﬂect accu-
rate steady-state measurements of CBF (Shalak and Perlman, 2004).
We attempted to control for this by including data collected under clin-
ically stable conditions and normative parameters for dextrose and he-
moglobin. We focused on early recognition of autoregulatory
impairments in newbornswithHIE by interrogating the relationship be-
tween spontaneous changes in MAP and SctO2 measured at the bedside.
Such neonates with limited responses to hypothermia, if recognized
early, might beneﬁt from new or additional neuroprotective therapies
if they become available.
Transfer function analysis has been widely used to assess dynamic
cerebral autoregulation in preterm newborns (Tsuji et al., 2000; Soul
et al., 2007). These studies reported a pressure-passive status of im-
paired cerebral autoregulation as indicated by an in-phase coherence
between the spontaneous MAP and SctO2 changes. An intrinsic limita-
tion of transfer function analysis is that it is based on an assumption
that the changes inMAP and SctO2 are stationary, whichmay not always
hold in clinical settings such as HIE. Indeed, our data analysis indicates
that transfer function metrics represent the averaged data of phase, co-
herence and gain in the frequency domain and are unable to character-
ize the intermittent coherence between two signals (see
Supplementary material III). Alternatively, several studies used a mov-
ing window correlation method that estimated time-varying correla-
tion coefﬁcients between the spontaneous changes in MAP and SctO2
(Gilmore et al., 2011). The size of moving window was typically set at
30 min (Gilmore et al., 2011), which limited its capacity to assess cere-
bral autoregulation over multiple time scales.
Assessment of dynamic cerebral autoregulation using wavelet co-
herence makes no assumption about the stationarity of input signals.
A study by Latka et al. (2005) demonstrated that the phase dynamics
between the spontaneous changes in MAP and CBF velocity measured
in the middle cerebral artery (MCA), which was based on wavelet anal-
ysis, accounted for most of the nonlinear and non-stationary properties
of cerebral autoregulation. Another study by Rowley et al. (2007)
showed that thewavelet-based coherencewas useful for evaluating dy-
namic properties of cerebral autoregulation in autonomic failure pa-
tients in response to a short-duration posture change. In this study,
we appliedwavelet coherence analysis to assess dynamic cerebral auto-
regulation in neonates with HIE at multiple time scales, whichwere the
intrinsic characteristics of the continuously recorded MAP and SctO2
changes for up to 72 h. Wavelet-based metrics of phase, coherence,
130 F. Tian et al. / NeuroImage: Clinical 11 (2016) 124–132and gain were derived to quantify the severity of impaired cerebral
autoregulation. Preliminary ﬁndings suggest that these measures ap-
pear to be useful for predicting the short-term and long-term clinical
outcomes following hypothermic therapy.
In wavelet coherence analysis, statistical signiﬁcance of coherence
between the MAP and SctO2 changes was estimated using a Monte
Carlo simulation method, which generated a large ensemble of surro-
gate data pairs based on bootstrapping and an AR1 model. We con-
ﬁrmed that the estimated Fourier power spectra of MAP and SctO2
changes could be approximated by the AR1 model, which supports
the use of this method for statistical testing (Grinsted et al., 2004).
The main ﬁndings of this study indicate that cerebral autoregulation
in neonates with HIE is a time-scale-dependent phenomenon: Signiﬁ-
cant in-phase coherence between the MAP and SctO2 oscillations oc-
curred mostly in shorter time scales of ≤80 min with a peak of around
7.5 min, and signiﬁcant anti-phase coherence between these two oscil-
lations occurred in longer time scales of around 2.5 h. Both appeared to
be related toworse clinical outcomes. Ourﬁnding of the in-phase coher-
ence between MAP and SctO2 is in line with the previous ﬁndings of a
pressure-passive status of impaired cerebral autoregulation that
corresponded to changes occurring over several minutes (Tsuji et al.,
2000; Soul et al., 2007; Gilmore et al., 2011). However, our ﬁnding of
persistent anti-phase coherence between MAP and SctO2 oscillations at
a large time scale of about 2.5 h was unexpected. Currently, there are
no comparisons available at these large time scales from the literature.
The anti-phase coherence between MAP and SctO2 may have different
underlying pathophysiological mechanisms from those of the
pressure-passive status of impaired cerebral autoregulation, which
need to be elucidated in further studies. As discussed above, possible
confounders involve the properties of SctO2 which can be affected by ar-
terial saturation, CBF, cerebral blood volume and cerebral oxygen con-
sumption (van Bel et al., 2008; Chalak et al., 2014c). Therefore, these
variables need to be stable in order for SctO2 to reﬂect accurate steady-
state measurements of CBF (Shalak and Perlman, 2004). We attempted
to control for this by including data collected under clinically stable con-
ditions and normative parameters for dextrose and hemoglobin. The
newborns selected had stable cardiovascular variables with respect to
arterial oxygenation and ventilation, and body temperatures were
maintained constant at 33.5 °C for the duration of hypothermia. Cere-
bral hyperoxygenation, abnormally increased perfusion, and lack of
normal cerebral blood ﬂow regulation are typically present in severe
hypoxic–ischemic encephalopathy and are associated with poor
neurodevelopmental outcome (Toet et al., 2006), even when hypother-
mia is used (Lemmers et al., 2013). Such newborns were excluded from
study selection requiring stable hemodynamic measures, whichFig. 5. Estimated Fourier power spectrum density (PSD) of (a) spontaneous MAP oscillation
estimated based on the normalized MAP and SctO2 time series (the original time series dividedresulted in a less severely affected group, where adaptive mechanisms
could also be at play. For instance, with the time scale of 2 h, it is possible
that even though brain perfusion might be affected by reductions in ar-
terial pressure, redistribution of oxygenated blood related to the reduc-
tions in brain perfusion and neuronal metabolism could lead to an
increase in SctO2. Another possible explanation may rely on the charac-
teristics of spontaneousMAP and SctO2 oscillations in the power spectra.
Fig. 5 shows the estimated Fourier power spectra of the normalized
MAP and SctO2 oscillations for all theneonates based onWelch'smethod
(Welch, 1967). Distinct peaks in MAP are seen in time scales of 80 to
200 min, especially for neonates with abnormal outcomes, which are
echoed by the SctO2 data. Thus, it is possible that the long-term, anti-
phase coherence between MAP and SctO2 reﬂects a deleterious effect
of large blood pressure variability on brain oxygenation homeostasis
in newborns with HIE.
This study has several limitations. First, the current data were col-
lected from a small sample of neonates (n=9), which limited the abil-
ity to address moderate and severe encephalopathy separately. The
ﬁndings in the study need to be replicated in larger groups of patients.
Second, the data was sampled at two data points per minute as limited
by the available hardware for data collection during this study. Accord-
ing to theNyquist theorem, it only allowed a detection of frequencies up
to 0.017 Hz. The relationship between MAP and SctO2 changes in the
very low frequency range and higher (≥0.02 Hz), as deﬁned by previous
studies (Zhang et al., 2002), could not be explored. Third, although SctO2
has been widely used as a surrogate for CBF, in reality it represents a
composite result of blood oxygenation from the regional arterioles, cap-
illary vascular beds and post-capillary venues interrogated by NIRS. Re-
distribution of oxygenated blood among these blood vessels could affect
the SctO2 readings. Additional techniques for direct spot checks mea-
sures of CBF, such as TCD (Aaslid et al., 1982) or diffuse correlation spec-
troscopy (DCS) (Roche-Labarbe et al., 2010; Durduran and Yodh, 2014)
could be considered in future studies to complement the continuous
SctO2 measurements. A major limitation of both new techniques to be
taken into account is the lack of ability to provide continuous measure-
ments over the long time scales of interest. Moreover, DCS is not readily
available outside of a few research centers. Also elegant studies (Volpe,
1981; Greisen, 2006, 2009) in the past few decades have described the
limitations of Doppler CBF velocity as a proxy of CBF when an arterial
cross sectional area is dynamically regulated.
5. Conclusions
Wavelet coherence analysis is a suitable and powerful tool to charac-
terize and quantify the dynamic status of cerebral autoregulation durings, and (b) spontaneous SctO2 oscillations in HIE neonates during hypothermia. PSD was
by their mean values) and, therefore, had an arbitrary unit (a.u.).
131F. Tian et al. / NeuroImage: Clinical 11 (2016) 124–132a long-lasting treatment such as hypothermia. Based on this method,
signiﬁcant in-phase and anti-phase coherence between spontaneous
oscillations in MAP and SctO2 were found in neonates with HIE during
hypothermic therapy; both appeared to be related toworse clinical out-
comes. These ﬁndings support the feasibility of using this method to as-
sess cerebral autoregulation in neonateswith HIE aswell as its potential
prognostic values for short- and long-termclinical outcomemeasures in
these patients.
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